Viewing Study NCT06281834


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-28 @ 12:12 AM
Study NCT ID: NCT06281834
Status: RECRUITING
Last Update Posted: 2024-12-24
First Post: 2024-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Sponsor: Brigham and Women's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module